This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Anthrogenesis Corporation. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Innovations in Sarcoidosis Treatment by Philippe Martin
Introduction
Philippe Martin is an innovative inventor based in Hoboken, NJ (US). He has made significant contributions to the field of medical treatments, particularly in addressing sarcoidosis, a complex inflammatory disease. His work focuses on utilizing placental stem cells to develop effective treatment methods for individuals suffering from this condition.
Latest Patents
Philippe Martin holds a patent for the "Treatment of sarcoidosis using placental stem cells." This patent describes methods for treating individuals with sarcoidosis or related diseases using placental cells. Additionally, it outlines kits that comprise placental stem cells or compositions thereof, which can be utilized in the treatment of sarcoidosis or related disorders. He has 1 patent to his name, showcasing his commitment to advancing medical science.
Career Highlights
Philippe Martin is associated with Anthrogenesis Corporation, a company dedicated to developing innovative therapies using stem cell technology. His role at the company has allowed him to explore groundbreaking approaches to treating complex diseases, particularly those that have limited treatment options.
Collaborations
Philippe has collaborated with notable professionals in his field, including Aleksandar Francki and Steven Alan Fischkoff. These collaborations have contributed to the advancement of research and development in stem cell applications for medical treatments.
Conclusion
Philippe Martin's work in the treatment of sarcoidosis using placental stem cells represents a significant advancement in medical innovation. His contributions highlight the potential of stem cell technology in addressing complex health issues.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile